Clinical Trial of Teriparatide in Japan

Assessment of Dose Response of LY333334 in Japanese Postmenopausal Women With Osteoporosis

The purpose of this study is to assess the Efficacy and Safety of Teriparatide in Japanese Postmenopausal Women with Osteoporosis.

Inclusion Criteria:

• Japanese women with primary osteoporosis
• Postmenopausal women aged at least 55 years
• Patients with a high risk for fracture

Exclusion Criteria:

• History of metabolic bone disorders other than osteoporosis
• History of any secondary causes of osteoporosis
• History of malignant neoplasm within the last 5 years except for superficial basal cell carcinoma or squamous cell carcinoma of the skin that has been definitively treated
• Severe or chronically disabling conditions other than osteoporosis